F-star Therapeutics, Inc.
Edit

F-star Therapeutics, Inc.

http://www.f-star.com/
Tags:BioTechDevelopmentDrugEstateManufacturingMedtechPlatformProductSpaceTechnology
F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer. F-star is pioneering the use of tetravalent (2+2) bispecific antibodies to create a paradigm shift in cancer therapy. The Company has four second-generation immuno-oncology therapeutics in the clinic, each directed against some of the most promising IO targets in drug development, including LAG-3 and CD137. F-star’s proprietary antibody discovery platform is protected by an extensive intellectual property estate. F-star has over 500 granted patents and pending patent applications relating to its platform technology and product pipeline. The Company has attracted multiple partnerships with biopharma targeting significant unmet needs across several disease areas, including oncology, immunology, and CNS.
Location: United Kingdom, England, Cambridge
Member count: 51-200
Total raised: $46.157752M
Founded date: 2006

Investors 6

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
23.10.2013Series A$12.945714...-mp-healthc...
13.04.2011-$21.694734...-finsmes.co...
06.01.2010Series A$11.517304...-finsmes.co...

Mentions in press and media 16

DateTitleDescriptionCategoryAuthorSource
03.12.2020F-star The... CAMBRIDGE, England and CAMBR...--prnewswire...
22.10.2020F-star The... CAMBRIDGE, England and CAMBR...--prnewswire...
27.02.2019Cofinitive...Cofinitive shortlisted for Int...--cambridgen...
07.06.2018F-star Ann...Cambridge, UK, 30 May 2018 – F...--tvm-lifesc...
05.06.2017F-star exp...F-star, a biopharmaceutical co...--cambridgen...
05.06.2017F-star exp...F-star expands its relationshi...--cambridgen...
28.04.2017Bris­tol-M...John Hau­rum → A lit­tle more...-Shehla Sha...endpts.com...
25.08.2016De­nali gr...South San Fran­cis­co-based up...FinancingJohn Carro...endpts.com...
30.10.2014TVM Capita...TVM Capital Life Science count...--tvm-lifesc...
23.10.2013F-star ann...---mp-healthc...
Show more